biote Corp.
BTMD · XNASCIK 1819253fmd_0MR6C7067YJXCF06ZCDV4NCEK4Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 02, 2020 to Sep 30, 2026, 25 periods
Latest annual · FY2025
Millions- Total revenues
- 192
- Operating income
- 36
- Net income
- 27
- Free cash flow
- 30
Latest quarter · Q3 FY2026
Millions- Total revenues
- 43
- Operating income
- 2
- Net income
- 0
- Free cash flow
- 1
Daily close · BTMDIEX trades only
Nov 13, 2025 to Nov 11, 2026 · 250 sessions1.11 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- +5.2%
biote Corp. (BTMD) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $192.2 million | $197.2 million | -2.5% | 10-K 2026-03-13 · proof |
| Operating income | $35.6 million | $31.6 million | +12.5% | 10-K 2026-03-13 · proof |
| Net income | $27 million | $3.2 million | +756.7% | 10-K 2026-03-13 · proof |
| Cash from operating activities | $35.2 million | $45.2 million | -22.2% | 10-K 2026-03-13 · proof |
| Free cash flow | $30.2 million | $38.8 million | -22.2% | 10-K 2026-03-13 · proof |
| Total assets | $107.6 million | $122.4 million | -12.1% | 10-K 2026-03-13 · proof |
| Total liabilities | $158 million | $224.6 million | -29.6% | 10-K 2026-03-13 · proof |
| Cash and cash equivalents | $24.1 million | $39.3 million | -38.7% | 10-K 2026-03-13 · proof |
| Total debt | $102 million | $107.4 million | -5% | 10-K 2026-03-13 · proof |
- What was biote Corp. (BTMD)'s revenue in fiscal 2025?
- biote Corp. (BTMD) reported revenue of $192.2 million for fiscal 2025 (the year ended Dec 31, 2025), against $197.2 million the year before (-2.5%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What was biote Corp. (BTMD)'s operating income in fiscal 2025?
- biote Corp. (BTMD) reported operating income of $35.6 million for fiscal 2025 (the year ended Dec 31, 2025), against $31.6 million the year before (+12.5%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What was biote Corp. (BTMD)'s net income in fiscal 2025?
- biote Corp. (BTMD) reported net income of $27 million for fiscal 2025 (the year ended Dec 31, 2025), against $3.2 million the year before (+756.7%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What was biote Corp. (BTMD)'s cash from operating activities in fiscal 2025?
- biote Corp. (BTMD) reported cash from operating activities of $35.2 million for fiscal 2025 (the year ended Dec 31, 2025), against $45.2 million the year before (-22.2%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What was biote Corp. (BTMD)'s free cash flow in fiscal 2025?
- biote Corp. (BTMD) reported free cash flow of $30.2 million for fiscal 2025 (the year ended Dec 31, 2025), against $38.8 million the year before (-22.2%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What are biote Corp. (BTMD)'s total assets?
- As of Dec 31, 2025, biote Corp. (BTMD) reported total assets of $107.6 million, against $122.4 million a year earlier (-12.1%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What are biote Corp. (BTMD)'s total liabilities?
- As of Dec 31, 2025, biote Corp. (BTMD) reported total liabilities of $158 million, against $224.6 million a year earlier (-29.6%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What are biote Corp. (BTMD)'s cash and cash equivalents?
- As of Dec 31, 2025, biote Corp. (BTMD) reported cash and cash equivalents of $24.1 million, against $39.3 million a year earlier (-38.7%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
- What is biote Corp. (BTMD)'s total debt?
- As of Dec 31, 2025, biote Corp. (BTMD) reported total debt of $102 million, against $107.4 million a year earlier (-5%). Source: the 10-K filed with the SEC on Mar 13, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:BTMD&period_type=annual&limit=5"Information only, not investment advice.